Hexa Research
Fact-based market research , penetrating industry insights and validated forecasts to help you make better decisions for a stronger future
rapidly growing segment due to the efficacy of nano particles to fight against cancerous tissues & tumors .
Browse Details of Report @ https :// www . hexaresearch . com / research-report / healthcarenanotechnology-industry
High incidence of cardiovascular anomalies can augment the cardiovascular segment over the forecast period . The market for nanotechnology applications in cardiology holds high growth potential in most developing & underdeveloped economies . The anti-infective segment is projected to expand considerably because of rising prevalence of air -borne diseases , bird flu , and swine flu . Based on end users , the market is trifurcated into ambulatories , clinics , and hospitals .
The hospitals segment may expand substantially owing to rising cases of chronic ailments and high awareness about disease prevention . A number of large and medium sized hospitals have begun adopting nanotechnology . Unlike small hospitals that have limited resources , the large ones can adopt newer technologies because of favorable budgetary conditions .
Geographically , the global industry is divided into Asia Pacific , North America , Europe , and Rest of the World . North America held the highest share in terms of revenue in 2014 . Factors , such as high investments and sophisticated technologies can fuel this region in the forthcoming years . Ongoing industry trends suggest that Asia Pacific may register a high rate of growth at the same time . Key regional drivers are surging disposable incomes , outsourcing of healthcare services , and growing population .
Prominent companies operating in the worldwide healthcare nanotechnology market are Celgene Corporation , CombiMatrix Corporation , Johnson & Johnson , Abbott Laboratories ,
Contact : + 1-800-489-3075
Email : sales @ hexaresearch . com Website : http :// www . hexaresearch . com /